MedTrace Logo

The Effect of an Edible Algal Extract (Ulva Lactuca) on the Component of Depression in Healthy Volunteers With Anhedonia

NCT03545399 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-06-04

No results posted yet for this study

Summary

The effects of the seaweed extract were evaluated on the animal model equivalent of depression compared with a control group treated with the carrier (spring water) and a reference group treated with Imipramine and showed significative effect. This clinical trial was intended to confirm in humans the potential efficacy identified in animals. The primary objective was to compare against a placebo the effect of Ulva L.L extract in healthy volunteers whose anhedonia was characterized by a component of depression.

Conditions

  • Anhedonia in Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Ulva Lactuca

The dose was taken with a glass of water during the evening meal once daily

DIETARY_SUPPLEMENT

Placebo

The dose was taken with a glass of water during the evening meal once daily

Sponsors & Collaborators

  • CEN Nutriment

    collaborator UNKNOWN

  • Biovet Conseil

    collaborator UNKNOWN

  • Amadeite SAS

    collaborator UNKNOWN

  • CEN Biotech

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-29
Primary Completion
2016-05-31
Completion
2016-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03545399 on ClinicalTrials.gov